Exercise may fix blood vessels in obesity, study hints
NCT ID NCT04087655
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how exercise improves blood vessel function in people with obesity. Researchers will measure oxidative stress and blood flow in the muscle before and after an 8-week interval training program. The goal is to understand the role of a specific enzyme (NADPH oxidase) in causing blood vessel problems. 25 sedentary obese adults with metabolic syndrome will participate.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- interval exercise training
- What this could lead to
- If successful, this study could reveal exactly how exercise improves blood vessel health in obesity, pointing toward better exercise-based treatments.
- What could go wrong
- This is a small, early-stage study (25 people) focused on understanding mechanisms, not testing a new treatment. Results may not apply to all obese individuals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 25 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2019
- Expected to finish
-
May 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 45 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * There will be no restrictions with regard to race, sex, or socioeconomic status. * Women will be premenopausal * Women will be on combined estrogen/progestin hormonal contraceptive therapy (oral pill, transdermal patch or vaginal ring). * Sedentary obese individuals will have been weight stable for the preceding 6 months. * Sedentary obese individuals will have the Metabolic Syndrome as defined according to the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). * Individuals with the Metabolic Syndrome will have at least three of the following: 1. Central obesity as measured by waist circumference (men \>40 inches; women \>35 inches); 2. Fasting blood triglycerides \> 150 mg/dL; 3. Blood HDL cholesterol in men\<40 mg/dL and women \<50 mg/dL; 4. Blood pressure \> 130/85 mmHg; 5) Fasting blood glucose \> 110 mg/dL, and (not per ATP III) a 2-hour GTT glucose of 140-200 mg/dl. Exclusion Criteria: * Subjects participating in purposeful endurance exercise training (\>20 min/day, \>1 day/week) will be excluded. * Pre-menopausal female subjects must not be pregnant or lactating, and must have had regular menstrual cycles for the past year. * Individuals taking medications that may affect central or peripheral circulation, * Individuals on nonsteroidal anti-inflammatory agents or serotonin reuptake inhibitors, * Individuals who smoke or chew tobacco, * Individuals with diabetes (fasting blood glucose \>125 mg/dL), * hypertension \>160/95 mmHg * Individuals with congestive heart failure, angina, or peripheral vascular disease. --Individuals with ECG evidence of serious arrhythmias and/or acute myocardial ischemia reflected in ST-segment depression of 1 mm or greater at rest or during exercise. * Individuals with chronic infections, paralysis due to stroke, advanced Parkinson's Disease, severe rheumatoid arthritis or other serious orthopedic problems that would prevent performance of the exercise training tasks will be excluded. * Individuals taking antioxidant, herbal or vitamin supplementation for at least 2 weeks prior to investigation. * Individuals ingesting caffeine the day of the experiment. * Individuals whose weight changes by more than 5% during the training program. * Individuals whose exercise adherence is below 90% of the exercise sessions or total exercise time.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Endothelial dysfunction are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Florida State University
RECRUITINGTallahassee, Florida, 32306, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- The acute effects of an endurance exercise bout the gut microbiome and gut-derived metabolome in Women's distinct fitness and body mass indexes
- Pilot study to evaluate the effect of nicotinamide riboside on immune activation in psoriasis
- The feasibility of electrical impedance tomography to guide non-invasive respiratory interventions in chronic respiratory disease
- Longevity metrics AI/ML development study: a standing data library and Model-Development platform for predicting and validating health measurements, longevity, and disease
- Can a new injection help tackle obesity? a trial puts it to the test
- Does a Mother's weight change the chemistry of her breast milk?